Newsfeeds - Spark Newswire

3 minute read

New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy; Owen Hughes Appointed Executive Chairman Of The Board Of Directors; Jim Neal Has Retired As Chief Executive Officer

January 4, 9:49 AM

XOMA Corporation (NASDAQ:XOMA), the Biotech Royalty Aggregator, announced today Jim Neal has retired as Chief Executive Officer and two finance and biotechnology industry veterans have joined in newly created executive

XOMA

1 minute read

News

XOMA Corp On Sept. 28 Made $3M Milestone Payment To Affitech Research As Pursuant To Commercial Payment Purchase Agreement

By Benzinga Newsdesk

September 29, 6:14 AM

- Reuters

XOMA

10 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 8, 12:08 PM

On Thursday, 168 companies reached new 52-week lows.

ACCO

2 minute read

M&A
News

Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers $2.5M Milestone Payment to XOMA

By Charles Gross

June 2, 5:29 AM

Kuros Biosciences AG ("Kuros" or the "Company"), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN).

CMPI

57 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

May 6, 12:06 PM

On Friday, 1043 companies hit new 52-week lows.

AAOI

1 minute read

XOMA Q1 EPS $(0.32) Up From $(0.70) YoY

By Bill Haddad

May 5, 7:52 AM

XOMA (NASDAQ:XOMA) reported quarterly losses of $(0.32) per share. This is a 54.29 percent increase over losses of $(0.70) per share from the same period last year.

XOMA

2 minute read

Earnings

XOMA’s Return On Capital Employed Insights

By Benzinga Insights

March 10, 10:52 AM

According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales, a 3723.83% increase since Q3.

XOMA